Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model
Abstract Background Topical administration of PR022, 0.05% hypochlorous acid (HOCl) in gel has been demonstrated to be beneficial in a chronic murine atopic dermatitis model. In a follow up study we tested a higher concentration (0.1%) of PR022 HOCl gel in comparison to the Janus kinase inhibitor to...
Saved in:
Main Authors: | Tomoki Fukuyama (Author), Sarah Ehling (Author), Jenny Wilzopolski (Author), Wolfgang Bäumer (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuromedin B Induces Acute Itch in Mice via the Activation of Peripheral Sensory Neurons
by: Sarah Ehling, et al.
Published: (2019) -
Comparing the effectiveness of topical fluticasone 0.05% cream versus topical tacrolimus 0.1% ointment in pediatric atopic dermatitis: A randomized controlled trial
by: Sanjeev Handa, et al.
Published: (2022) -
Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
by: Rebekka Christmann, et al.
Published: (2020) -
Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021) -
Combination Therapy of Oral Tofacitinib with Phototherapy in Severe Pediatric Atopic Dermatitis
by: Ananya Pramanik, et al.
Published: (2024)